chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride · Haleon Us Holdings · NDA 021441
Advil Allergy Sinus
Earliest generic entry, as listed
28 Feb 2027
Blocked by patent: US 7863287.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7863287 | product | 28 Feb 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 24 Oct 2026Enters 12-month window basis: patent · 021441-00128 Feb 2027
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021441 · 001 · RLD | tablet, oral | 2MG;200MG;30MG | 28 Feb 2027 |